New Paper published: Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma

Very excited to announce that our latest work, a joint collaboration led by fantastic Dr David Croucher and his lab at the Garvan Institute has just been published in the leading international journal eLife1. You can download and access the full article for free here [Link]. Key Points we made in the paper are: Most […]

Read More New Paper published: Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma

New Review Article: Breathing New Life into the Mechanisms of Platinum Resistance

Very excited to announce our latest mini-review/commentary article where we discuss the latest breakthroughs in the mechanism of Platinum chemotherapy resistance in Lung Adenocarcinoma. You can access the full article here for free [Link] You can also vote for our graphical abstract here in the BioRender art competion: https://app.biorender.com/contest/profile/5c536990917d2d0016e78a54-andrew-burgess/s-5eb4ba5c5aa21500b50a1732-mechanisms-of-cisplatin-resistance-in-lung-cancer

Read More New Review Article: Breathing New Life into the Mechanisms of Platinum Resistance

New Review: The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma

Very excited to announce a new review from our PhD student Tom Johnson, in collaboration with Glen Reid’s laboratory, has been accepted and published in Frontiers in Cell and Developmental Biology. Its an excellent, comprehensive review of of the oncoprotein YB-1 in Lung Cancer and Mesothelioma. The review article is Open Access and free for […]

Read More New Review: The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma

New Co-Author paper out now in SciTransMed: Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

Very exciting day to see this amazing work by the lab of Prof.Neil Watkins published in the prestigious Science Translational Medicine Journal. A huge amount of work for a lot of very talented people over many many years went into this study, and hopefully it will result in significant improvements for the treatment of lung […]

Read More New Co-Author paper out now in SciTransMed: Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

New Co-author Publication: Hic1 maintains chromosomal stability independent of p53

Great news, we have a new co-author publication out in the journal Oncogene! The work was lead by Professor Neil Watkins, and is titled “The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53”. You can access the full article here [Link] ABSTRACT: Hypermethylated-in-Cancer 1 (Hic1) is a tumor suppressor gene frequently inactivated by epigenetic […]

Read More New Co-author Publication: Hic1 maintains chromosomal stability independent of p53